Porzio Giampiero, Aielli Federica, Verna Lucilla, Porto Claudio, Aloisi Paolo, Cannita Katia, Ricevuto Enrico, Marchetti Paolo, Ficorella Corrado
Supportive Care Task Force, Medical Oncology Department, University of L'Aquila, L'Aquila, Italy.
Support Care Cancer. 2006 Apr;14(4):389-91. doi: 10.1007/s00520-005-0014-5. Epub 2006 Jan 10.
Nine patients with advanced cancer suffering from idiopathic severe sweating were treated with gabapentin (600-1,800 mg/day). All patients responded to the treatment; five patients experienced transient drowsiness. Gabapentin seems to be a safe and effective treatment for idiopathic sweating in advanced cancer patients. Further studies are warranted to confirm or refute these results.
9例患有特发性严重出汗的晚期癌症患者接受了加巴喷丁治疗(600 - 1800毫克/天)。所有患者对治疗均有反应;5例患者出现短暂嗜睡。加巴喷丁似乎是晚期癌症患者特发性出汗的一种安全有效的治疗方法。有必要进行进一步研究以证实或反驳这些结果。